ERBB2 and neoplasm: In this older group, no significant difference was recognized in the tumor size, lymph node metastasis, nuclear grade, PR expression, HER2 status, or administration of adjuvant chemotherapy between the patients with and without adjuvant hormone therapy (data not shown).